» Articles » PMID: 17593389

Hypercalciuria is the Main Renal Abnormality Finding in Human Immunodeficiency Virus-infected Children in Venezuela

Overview
Journal Eur J Pediatr
Specialty Pediatrics
Date 2007 Jun 27
PMID 17593389
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Kidney involvement in children with Human Immunodeficiency Virus (HIV) infection is increasing in prevalence in parallel with the longer survival of HIV-infected patients and the side-effects of new antiretroviral drugs. However, there are only a few reports describing renal tubular disorders in HIV+ children. This is a cross-sectional, case series study evaluating kidney disease in 26 Venezuelan HIV-infected children. The study cohort consisted of 15 girls and 11 boys, with a median age of 5.9 years (25-75th percentile: 3.6-7.8), who had been treated with antiretrovirals for 2.8 +/- 0.4 years, Overall, the patients were short for their age and gender (Z-height: -3.1; 25-75th percentile: -4.94 to -1.98), and 15 showed signs of mild to moderate malnutrition. All of the children had a normal estimated glomerular filtration rate (136 +/- 22.6 ml/min/1.73 m2), and glomerular involvement was only observed in one patient with isolated proteinuria. None had nephromegaly. In contrast, tubular disorders were commonly found. Hypercalciuria was detected in 16 of the patients (UCa/Cr = 0.28; 25-75th percentile: 0.17-0.54 mg/mg), with five of these showing crystalluria. Eight children showed hyperchloremia, and three had frank metabolic acidosis. Kidney stones were absent in all, but one boy had bilateral medullary nephrocalcinosis. Conclusion, in Venezuelan children, HIV infection per se, or its specific treatment, was commonly associated with renal tubular dysfunction, especially hypercalciuria and acidosis, potentially leading to nephrocalcinosis and growth impairment. We recommend renal tubular evaluation during the follow-up of children with HIV infection.

Citing Articles

Extracellular Calcium Receptor as a Target for Glutathione and Its Derivatives.

Goralski T, Ram J Int J Mol Sci. 2022; 23(2).

PMID: 35054903 PMC: 8776003. DOI: 10.3390/ijms23020717.


Urinary biomarkers of kidney diseases in HIV-infected children.

Perazzo S, Soler-Garcia A, Hathout Y, Das J, Ray P Proteomics Clin Appl. 2015; 9(5-6):490-500.

PMID: 25764519 PMC: 4530778. DOI: 10.1002/prca.201400193.


Kidney disease in HIV-positive children.

McCulloch M, Ray P Semin Nephrol. 2008; 28(6):585-94.

PMID: 19013330 PMC: 2778302. DOI: 10.1016/j.semnephrol.2008.09.001.

References
1.
Gerstoft J, Kirk O, Obel N, Pedersen C, Mathiesen L, Nielsen H . Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine. AIDS. 2003; 17(14):2045-52. DOI: 10.1097/00002030-200309260-00005. View

2.
Moyle G, Datta D, Mandalia S, Morlese J, Asboe D, Gazzard B . Hyperlactataemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors. AIDS. 2002; 16(10):1341-9. DOI: 10.1097/00002030-200207050-00005. View

3.
PRENCIPE L, Fossati P, VANZETTI G . [Enzymatic determination of uric acid in serum with the trinder reaction (author's transl)]. Quad Sclavo Diagn. 1978; 15(3):382-94. View

4.
Ghazali A, Fuentes V, Desaint C, Bataille P, Westeel A, Brazier M . Low bone mineral density and peripheral blood monocyte activation profile in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab. 1997; 82(1):32-8. DOI: 10.1210/jcem.82.1.3649. View

5.
Boubaker K, Sudre P, Bally F, Vogel G, Meuwly J, Glauser M . Changes in renal function associated with indinavir. AIDS. 1999; 12(18):F249-54. DOI: 10.1097/00002030-199818000-00003. View